RSC Advances
Paper
exchange process. Typically, 1.0
g SO3H@zeolite-Y in
2.4.2. 3-(1H-Benzo[d]imidazol-2-yl)-2-(2-chlorophenyl)thiazolidin-
4-one (4g). IR (KBr) (nmax): 3444, 3349 (NH), 2925 (C–H), 1683
(C]O), 1535 (C]N), 1447, 1303, 1269 (C]C), 1170 (C–N), 743,
647 (C–S–C) cmꢁ1; 1H-NMR (500 MHz, DMSO-d6) dH: 3.97 (1H, d,
J ¼ 16.50 Hz, SCH2), 4.11 (1H, d, J ¼ 16.45 Hz, SCH2), 6.85 (1H, s,
CH), 7.06–7.15 (3H, m, H–Ar), 7.24 (1H, t, J ¼ 7.55 Hz, H–Ar),
7.30 (1H, t, J ¼ 7.60 Hz, H–Ar), 7.38 (1H, d, J ¼ 7.90 Hz, H–Ar),
7.53 (2H, t, J ¼ 7.60 Hz, H–Ar), 12.52 (1H, s, NH) ppm; 13C-NMR
(125 MHz, DMSO-d6) dC: 32.1, 59.5, 112.4, 118.2, 122.0, 122.2,
125.2, 128.1, 129.9, 130.5, 131.5, 133.3, 138.3, 140.2, 144.7,
172.2 ppm; MS (m/z, %): 329 (M+, 10), 294 (100), 252 (30), 220
(94), 135 (30), 118 (20), 91 (18).
a 150 mL ask was added to an aqueous solution of NiCl2-
$2H2O (2 mM, 50 mL) at ambient temperature. The mixture
was stirred for 20 h and then it was ltered. The resulting
precipitate was washed repeatedly with water until negative
reaction of Clꢁ using AgNO3 test. The Ni/SO3H@zeolite-Y
nanocomposite was placed undꢀer ultrasound irradiations
for 30 min, and then dried at 70 C for 2 h.
2.3. General procedure for the preparation of 1,3-
thiazolidin-4-ones
2.4.3. 3-(Benzo[d]thiazol-2-yl)-2-(2-hydroxyphenyl)thiazolidin-
4-one (4k). IR (KBr) (nmax): 1700 (C]O), 1532 (C]N), 1381, 1269
(C]C), 1117 (C–N), 655 (C–S–C) cmꢁ1; 1H-NMR (300 MHz, DMSO-
d6) dH: 3.95 (1H, d, J ¼ 16.59 Hz, SCH2), 4.09 (1H, d, J ¼ 16.56 Hz,
SCH2), 6.68 (1H, t, J ¼ 7.28 Hz, CH), 6.83 (3H, q, J ¼ 8.78 Hz, H–Ar),
7.08 (1H, t, J ¼ 7.42 Hz, H–Ar), 7.28–7.40 (2H, m, H–Ar), 7.64 (1H, d,
J ¼ 7.8 Hz, H–Ar), 7.99 (1H, d, J ¼ 7.58 Hz, H–Ar), 10.12 (1H, s,
OH) ppm; 13C-NMR (75 MHz, DMSO-d6) dC: 32.3, 59.5, 115.6, 118.8,
121.2, 121.8, 124.2, 125.0, 126.2, 126.4, 128.9, 131.3, 147.7, 154.2,
156.0, 172.1 ppm; MS (m/z, %): 328.6 (M+, 48), 255.6 (100), 237.6
(9.3), 177.5 (21), 137.5 (27), 108.4 (11), 91.5 (8).
A mixture of aldehyde (1 mmol), 2-aminobenzimidazole or 2-
aminobenzothiazole (1.1 mmol), thioglicolic acid (1.2 mmol) and
5%w the Ni/SO3H@zeolite-Y (0.007 g) in 5 mL H2O/acetone (1 : 1)
was mixed at room temperature. Aer satisfactory completion of
the organic reaction (TLC monitoring using hexane and ethyl
acetate (2 : 1) as eluents), The catalyst was separated by simple
ltration and ltrate was added to 10 mL of cold water and
precipitate was ltered off and washed with cold ethanol–water
mixture. The desired product was puried by recrystallization in
ethanol–water and air dried. The known 1,3-thiazolidin-4-one
products were characterized by comparing the results of phys-
ical and spectroscopic data with those of the authentic samples.
The new N-benzothiazole-1,3-thiazolidinones were identied by
FT-IR, 1H NMR, 13C NMR and mass spectroscopy.
2.4.4. 3-(Benzo[d]thiazol-2-yl)-2-(3-nitrophenyl)thiazolidin-
4-one (4l). IR (KBr) (nmax): 1690 (C]O), 1617, 1537 (C]N), 1467,
1369, 1274 (C]C), 1349, 1530 (NO2), 1228 (C–N), 658 (C–S–
C) cmꢁ1
;
1H-NMR (300 MHz, DMSO-d6) dH: 4.02 (1H, d, J ¼
16.73 Hz, SCH2), 4.32 (1H, d, J ¼ 16.71 Hz, SCH2), 7.06 (1H, s,
CH), 7.29–7.40 (2H, m, H–Ar), 7.62 (2H, t, J ¼ 7.78 Hz, H–Ar),
7.86 (1H, d, J ¼ 7.77 Hz, H–Ar), 8.00 (1H, d, J ¼ 7.45 Hz, H–Ar),
8.10 (1H, q, J ¼ 1.35 Hz, H–Ar), 8.34 (1H, s, H–Ar) ppm; 13C-NMR
(75 MHz, DMSO-d6) dC: 171.6, 155.9, 147.8, 147.5, 143.4, 131.8,
131.2, 130.3, 126.4, 124.4, 122.9, 121.9, 121.2, 120.8, 61.8,
31.8 ppm; MS (m/z, %): 357.6 (M+, 100), 315.6 (57), 284.6 (62.5),
255.6 (32.6), 237.6 (32.7), 181.5 (33.2), 135 (56).
2.4. Spectroscopic data for the new compounds
2.4.1. 3-(1H-Benzo[d]imidazol-2-yl)-2-(2-nitrophenyl)thiazolidin-
4-one (4c). FT-IR (KBr) (nmax): 3437, 3338 (NH), 2929 (C–H), 1703
(C]O), 1650, 1540 (C]N), 1520, 1338 (NO2), 1455, 1369 (C]C),
1118 (C–N), 1024, 668 (C–S–C) cmꢁ1; 1H-NMR (500 MHz, DMSO-
d6) dH: 3.39 (1H, d, J ¼ 16.55 Hz, SCH2), 4.21 (1H, d, J ¼ 16.55 Hz,
SCH2), 7.06 (3H, d br, CH and H–Ar), 7.43 (2H, s br, H–Ar), 7.47
(1H, d, J ¼ 7.90 Hz, H–Ar), 7.55 (1H, t, J ¼ 7.55 Hz, H–Ar), 8.17
(1H, d, J ¼ 8.10 Hz, H–Ar), 12.51 (1H, br, NH) ppm; 13C-NMR
(125 MHz, DMSO-d6) dC: 32.2, 58.2, 122.2, 126.0, 126.1, 129.8
(2C), 135.5, 137.2 (2C), 144.8, 146.8, 172.1 ppm; MS (m/z, %): 340
(M+, 30), 294 (32), 220 (65), 206 (30), 178 (25), 160 (100), 133 (25),
104 (18), 90 (20), 77 (18).
2.4.5. 3-(Benzo[d]thiazol-2-yl)-2-(4-nitrophenyl)thiazolidin-
4-one (4m). IR (KBr) (nmax): 1690 (C]O), 1617, 1537 (C]N),
1467, 1369, 1274 (C]C), 1349, 1530 (NO2), 1228 (C–N), 658 (C–
1
S–C) cmꢁ1; H-NMR (300 MHz, DMSO-d6) dH: 4.03 (1H, d, J ¼
16.73 Hz, SCH2), 4.28 (1H, d, J ¼ 16.67 Hz, SCH2), 7.03 (1H, s,
CH), 7.29–7.41 (2H, m, H–Ar), 7.61 (1H, d, J ¼ 7.53 Hz, H–Ar),
Scheme 2 Systematic approach for the preparation of Ni/SO3H@zeolite-Y.
41412 | RSC Adv., 2020, 10, 41410–41423
This journal is © The Royal Society of Chemistry 2020